Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Barrett

Showing results (431-440 of 434) with videos related to

Pageof 44
Sort By:
You have reached the last page of results.This site can display upto 434 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2018
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancerC Cruz, M Castroviejo-Bermejo, S Gutiérrez-Enríquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancerA C Garrido-Castro, S E Kim, T Li, et al.
Clinical Pharmacology and Therapeutics|February 11, 2017
Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) ConsortiumR L Grossman, B Abel, S Angiuoli, et al.
Molecular Psychiatry|February 12, 2014
A genome-wide association study of anorexia nervosaV Boraska, C S Franklin, J A B Floyd, et al.
Pageof 44

Showing results (431-440 of 434) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 434 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2018
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancerC Cruz, M Castroviejo-Bermejo, S Gutiérrez-Enríquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancerA C Garrido-Castro, S E Kim, T Li, et al.
Clinical Pharmacology and Therapeutics|February 11, 2017
Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) ConsortiumR L Grossman, B Abel, S Angiuoli, et al.
Molecular Psychiatry|February 12, 2014
A genome-wide association study of anorexia nervosaV Boraska, C S Franklin, J A B Floyd, et al.
Pageof 44